The present disclosure is directed to new inhibitors of the p38 mitogen-activated protein kinase having the general formula (I), processes for preparation thereof, pharmaceutical compositions thereof, and methods of use thereof.
本公开涉及新的p38丝裂原活化蛋白激酶
抑制剂,其具有一般式(I),其制备方法,其药物组合物以及其使用方法。